Wird geladen...
Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
BACKGROUND: Palbociclib is a selective well-tolerated antineoplastic drug used in the treatment of advanced HER2-negative, estrogen-receptor positive breast cancer that has shown significant improvement in progression-free survival. We present a patient that developed severe rhabdomyolysis with tetr...
Gespeichert in:
| Veröffentlicht in: | BMC Neurol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806583/ https://ncbi.nlm.nih.gov/pubmed/31640597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1490-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|